Review
Copyright ©The Author(s) 2018.
World J Hepatol. Sep 27, 2018; 10(9): 571-584
Published online Sep 27, 2018. doi: 10.4254/wjh.v10.i9.571
Table 6 Clinical characteristics of three advanced hepatocellular carcinoma patients with complete response who have survived over 10 years
Age diagnosed as HCCSexEtiologyChild-PughTumor stage1Previous treatmentMaximum tumor size (mm)Vascular invasion1RegimenTherapeutic effectAFP (ng/mL)DCP (mAU/mL)HCC recurrencePrognosisCause of death
67MaleHCVA (5)IVANone110Vp4, Vv0Low-dose FPCR12070026062 mo151 mo (dead)Hepatic failure
66MaleHCVA (5)IIINone50Vp0, Vv0Low-dose FP + IVCR6.42970None176 mo (dead)Larynx cancer
44MaleHBVB (7)IIINone150Vp3, Vv3Low-dose FP + IV + Peg IFNCR7145233640None148 mo (alive2)-